- ›
- Tags ›
BioPharma
In this podcast, Nick Ismail and Anjana Singh discuss scaling generative AI from pilot projects to full scale production

Leaders from Blue Yonder and HCLTech discuss the transformative impact of advanced technologies on global supply chains
At HCLTech, our focus is on enhancing drug safety through a comprehensive suite of client-based services. These services are designed to cater to the critically unique needs of our clients.
In this podcast, Nick Ismail is joined by Chirag Modi, former Corporate Vice President of Global Industry Strategy at Blue Yonder and Sadagopan Singam

How to streamline processes and leverage data-driven insights to enhance sustainability within supply chains

Harnessing AI's potential for strategic planning and execution within supply chains leads to unprecedented returns on investment
HCLTech’s advanced case intake system automates data extraction, validation, and prioritization from various sources. It streamlines workflow management and enhances pharmacovigilance efficiency.

Personalization and AI-powered CX can help companies win the battle for customer attention

In a recent HCLTech Trends and Insights podcast episode, Alan Flower discussed how generative AI (GenAI) is revolutionizing AI and spurring innovation across industries
The discussion includes the implications of digitization, automation, shift left strategy, and augmentation for the (near) future workforce.
Collaboration to help enterprises explore and develop GenAI-led use cases, proofs of concept, tools and solutions
HCLTech defined a unified platform program for a Danish pharma enterprise